Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

BACKGROUND AND AIMS: Patients with intermediate-stage hepatocellular carcinoma (HCC) refractory to transcatheter arterial chemoembolization (TACE) are considered to be candidates for sorafenib. The aim of this study was to evaluate the superiority of conversion of treatment to sorafenib on overall s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Liver Cancer
Glavni autori: Arizumi, Tadaaki, Ueshima, Kazuomi, Minami, Tomohiro, Kono, Masashi, Chishina, Hirokazu, Takita, Masahiro, Kitai, Satoshi, Inoue, Tatsuo, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Sakurai, Toshiharu, Nishida, Naoshi, Kudo, Masatoshi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2015
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698649/
https://ncbi.nlm.nih.gov/pubmed/26734579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000367743
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items